Clinical Trials Logo

Filter by:
NCT ID: NCT01532570 Completed - Behcet's Disease Clinical Trials

Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions

Start date: January 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of TA-650 in patients with Behcet's disease ( BD ) with special lesions after the administration of TA-650 at a dosage of 5 mg/kg in weeks 0, 2, and 6, then every 8 weeks after week 14 up to week 46.

NCT ID: NCT01529619 Completed - Alzheimer's Disease Clinical Trials

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Start date: March 2012
Phase: Phase 4
Study type: Interventional

This is a multicenter study to evaluate the efficacy, safety and tolerability of Rivastigmine patch in patients with mild to moderate Alzheimer's disease switched from Cholinesterase Inhibitors.

NCT ID: NCT01528735 Completed - Clinical trials for Hepatitis C, Chronic

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

Start date: February 2012
Phase: Phase 2
Study type: Interventional

The objective of this trial is to investigate tolerability, safety, pharmacokinetics and antiviral activity of BI 207127 NA in combination with BI 201335 NA and ribavirin for 8 weeks in Japanese treatment-naive patients with chronic GT-1 HCV infection.

NCT ID: NCT01528371 Completed - Clinical trials for Transient Hypertension

Effect of Midazolam on White-coat Hypertensive Dental Patients

Start date: October 2010
Phase: N/A
Study type: Interventional

Intravenous sedation was used for dealing with transient hypertension, so-called white-coat hypertension, before dental treatment. Midazolam used as a sedative also has antianxiety effect, and the mechanism is guessed that it minimizes patients' stress, resulting in the stability of blood pressure. The purpose of this randomized controlled trial (RCT) is to evaluate the effect of low dose of midazolam on blood pressure and anxiety scale in white-coat hypertensive dental patients.

NCT ID: NCT01528319 Completed - Clinical trials for Shoulder Dislocation

Open-Label Study for Shoulder Dislocation Using MG-1

MG-1
Start date: December 2011
Phase: N/A
Study type: Interventional

To evaluate the efficacy and safety of arthroscopic Bankart repair using MG-1 for dislocation of shoulder

NCT ID: NCT01527630 Completed - Clinical trials for Diabetes Mellitus, Type 2

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects

Start date: November 16, 2002
Phase: Phase 1
Study type: Interventional

This trial is conducted in Japan. The aim of this trial is to investigate the bioequivalence of two formulations of biphasic insulin aspart 50 (NN-X14Mix50) in healthy Japanese subjects.

NCT ID: NCT01527123 Completed - Acne Vulgaris Clinical Trials

A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris

Start date: February 28, 2012
Phase: Phase 1
Study type: Interventional

This is a Phase 1, single-center, open-label study to evaluate the pharmacokinetics of the BPO metabolites benzoic acid and hippuric acid with 7-day repeat application of GSK2585823 in subjects with acne vulgaris

NCT ID: NCT01527110 Completed - Influenza, Human Clinical Trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection

Start date: January 1, 2012
Phase: Phase 3
Study type: Interventional

This study will be an open-label, multi-center, single arm study to evaluate the safety and efficacy of IV zanamivir 600mg twice daily for 5 days in hospitalized subjects with laboratory confirmed influenza infection.

NCT ID: NCT01525641 Completed - Parkinson Disease Clinical Trials

Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

Start date: February 2012
Phase: N/A
Study type: Observational

Post-marketing surveillance (PMS) to investigate the safety and efficacy of long-term daily use of Mirapex®-LA Tablets in patients with Parkinson's disease.

NCT ID: NCT01525550 Completed - Clinical trials for Well-differentiated Pancreatic Neuroendocrine Tumor

A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Start date: June 6, 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to confirm the safety and efficacy of sunitinib in subjects with unresectable pancreatic neuroendocrine tumors.